We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
0
0 active
Approvals
Total approvals
Agencies
Regulatory bodies
Founded
N/A
No trial phase data available
No trial data available
No approval data available
- Singapore's National Centre for Infectious Diseases has conducted the country's first COVID-19 human challenge study, deliberately exposing five vaccinated volunteers to the virus under controlled conditions. - The Sing-CoV trial aims to recruit 20 healthy participants aged 21-30 by October 2024, with researchers collecting comprehensive biological samples to gain precise insights into infection dynamics despite vaccination. - This pioneering study establishes a framework for future challenge trials, including the upcoming global MUSICC study in 2025, strengthening Singapore's preparedness for future pandemics including potential "Disease X" threats.
